Logotype for T2 Biosystems Inc

T2 Biosystems (TTOO) investor relations material

T2 Biosystems Q4 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for T2 Biosystems Inc
Q4 2024 earnings summary7 Jan, 2025

Executive summary

  • Achieved record sepsis product revenues in Q4 2024 ($2.3M) and full year 2024 ($8.3M), up 37% and 23% year-over-year, respectively, driven by strong sepsis test sales.

  • Expanded global installed base with 27 T2Dx Instruments sold in 2024, including 23 internationally and 4 in the U.S.

  • Entered exclusive U.S. distribution agreement with Cardinal Health for key sepsis detection products.

  • Advanced product pipeline with FDA 510(k) clearances and progress on new diagnostic panels.

Financial highlights

  • Q4 2024 product revenue reached $2.3M, a 37% increase year-over-year; full year 2024 product revenue was $8.3M, up 23% year-over-year.

  • Cash and cash equivalents totaled $1.7M as of December 31, 2024.

  • Converted $30M of term loan into common stock, reducing debt and quarterly interest payments by approximately 80% over the past year.

Outlook and guidance

  • Expects exclusive Cardinal Health agreement to drive commercial growth in 2025.

  • Plans to accelerate product sales, enhance operations, and advance new product pipeline in 2025.

  • Anticipates FDA 510(k) submission for T2Resistance Panel in Q1 2025.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. The company develops integrated systems for implantable devices and other devices used to administer therapies and monitor outcomes. Its integrated systems provide measurement at the sensor, electronics, and software layers. The company also provides patient adherence monitoring solutions comprising portable medical devices, bio-markers, the Emeter® 2 diabetes management platform, and a new removable stent-based blood glucose meter that captures measurements directly from the body with a minimally invasive procedure called transcutaneous measuring technique (TMT). The company's Transmettor Plus integrates blood glucose data directly into Medtronic's MiniMed® Paradigm insulin pump as well as Dexcom's G4® CGM to improve overall glycemic control. It also offers technology platforms comprising biosensors, electronic circuits, adhesive arrays, and microfluidics for a range of diagnostic applications including potential use in point-of-care (POC) systems. T2 Biosystems is based in Lexington, Massachusetts.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage